SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

US FDA Approves GSK’s Second Lung Cancer Drug From Nuvalent Deal

The FDA approved GSK’s second lung cancer drug from its deal with Nuvalent.

PFE

Related stories